Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

United Bankers Corporation: Acquisition of Own Shares 12.11.2019

United Bankers Corporation NOTIFICATION   12.11.2019 at 18:30   UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 12.11.2019 Date 12.11.2019Exchange transaction BuyShare class UNIAVAmount 300Average price/share 8.5500 EURHighest price/share 8.5500 EURLowest price/share 8.5500 EURTotal price 2,565.00 EUR The shares held by United Bankers Corporation on 12.11.2019: UNIAV 34,520 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti

BEWiSynbra announces tender offer regarding outstanding SEK bonds

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Heimstaden Bostad issues hybrid capital

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

#19-1128 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

SpareBank 1 SR-Bank: Distribution of shares as part of the savings scheme for employees

The shares purchased by SpareBank 1 SR-Bank ASA 1, 4 and 5 November 2019 for use in the group's savings scheme for employees, have been distributed to the employees at a price of NOK 99,251  After allocation the banks total holding of own shares is 91.130 shares.  As participants in the savings scheme the primary insiders have acquired shares in accordance with the enclosed list.

Cimco Marine AB (publ) receives significant order for the OXE300 with a value of approx. EUR 3 million from one of its distributors in the Americas

Cimco Marine AB (publ) has today received orders for the OXE300 from one of its distributors in the Americas in respect to mainly governmental use. The total revenue for this order is approx. EUR 3 million for the base units, excluding accessories, service kits and spare parts.Delivery of the OXE300 units will commence once start of production commences, which is expected to be in the second quarter of 2020. The entire order is expected to be delivered during 2020. “I am extremely pleased that, following the successful marketing launch of the OXE300 at the Genoa Boat show in September,

Heimstaden Bostad issues hybrid capital

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Cederquist advisor to Vonovia in connection with the mandatory public offer on Hembla

Cederquist is legal advisor to Vonovia SE in connection with Vonovia's mandatory public offer on Hembla AB (publ). Hembla's class B shares are listed on Nasdaq Stockholm, in the Mid Cap segment.Earlier during the fall, Cederquist advised the German real estate company Vonovia in relation to Vonovia's acquisition of a majority stake in the Swedish real estate company Hembla. Upon completion of the share acquisition, a mandatory bid obligation was triggered and Vonovia has now launched a mandatory offer for the remaining shares in Hembla. The offer values Hembla, based on all outstanding

BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW

Lund, Sweden, 16:00 CET, November 12 2019 – BONESUPPORT™ an emerging leader in orthobiologics for the management of bone injuries, announces changes in its leadership team that will take place November 18, 2019. Fergus MacLeod starts in the position as the company´s General Manager & Executive Vice President Commercial Operations EUROW. Fergus MacLeod has more than 20 years of experience from international sales leadership positions within the Orthobiologics and Medical Devices sectors at companies like Johnson Matthey, RTI Surgical and Stryker. “Fergus MacLeod will be an important

Promore Pharma is granted a patent for PXL01 in the US

STOCKHOLM, November 12, 2019 – Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that its subsidiary Pergamum AB was granted a patent in the US for the pharmaceutical formulation of the product candidate PXL01.Promore Pharma’s subsidiary Pergamum owns the intellectual property rights of PXL01, which initially is being developed to prevent post-surgical adhesions after tendon repair surgery. The U.S. Patent Office (USPTO) issued a Notice of Allowance in June 2019 and the patent, which protects the formulation of PXL01 in combination with high

SciBase announces order of Nevisense from Mount Sinai Hospital’s New Melanoma Clinic

STOCKHOLM, Sweden, — November 12, 2019 — SciBase a leading developer of electrical impedance spectroscopy systems in dermatology, announced today that The Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai has become the first Health System in the United States to order multiple Nevisense systems in their new melanoma center.  The Mount Sinai health system encompasses eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region making it the largest system in the region. “We are excited about integrating

PEN design, manufactures and assembles 32 stands to  Elmia Subcontractor 12-15 november.

PEN Concept Group AB (PENCON, Spot Light Stock Market) will, through the subsidiary PEN Interiör AB, deliver a total of 32 stands to Elmia Subcontractor 12-15 November 2019. These will be designed, manufactured and assembled for multiple different customers. Total order value is about 2,0 MSEK. Elmia Subcontractor is the leading subcontractor fair in the north of Europe. Magnus Hjorth, CEO PEN Concept Group AB, explains: ”It is with great satisfaction I note that we continues to gain great confidence from our customers and that we consolidate our position as a supplier of exhibition

ESA and GomSpace sign contract addendum for continued development on the Juventas CubeSat in support of the Hera mission

GomSpace A/S and the European Space Agency (ESA) signed an addendum to continue development of the Juventas CubeSat in support of the Hera mission. The contract value is EUR 1,165,000 and the focus is on developing the nanosatellite payloads and maturing the mission and spacecraft designs. The amount will be divided between several partners, whereof GomSpace’s share is EUR 295,000. The Hera mission is part of the Asteroid Impact and Deflection Assessment (AIDA) international collaboration together with the NASA DART mission and it will travel to the binary asteroid system, Didymos.

SDLP - Seadrill Partners LLC Third Quarter 2019 Cash Distribution

London, United Kingdom, November 12, 2019 - Seadrill Partners LLC (OTCQB:SDLPF) ("Seadrill Partners" or the "Company") announces today that a distribution of $0.01 per unit has been declared with respect to the third quarter ended September 30, 2019, in line with the second quarter distribution. The third quarter cash distribution will be paid on November 27, 2019 to all unitholders of record as of the close of business on November 22, 2019. FORWARD LOOKING STATEMENTSThis news release includes forward looking statements. Such statements are generally not historical in nature, and

Updated timetable for submission of the application to the European Medicines Agency

Intervacc will shortly apply to the European Medicines Agency (EMA) to submit the company's registration application for Strangvac's approval during the first quarter of 2020. The company has today decided to enter into a dialogue with EMA about submitting the registration application, provisionally at the end of February. Until then the company will strengthen the application and ensure that all the guidance of our expert advisor and the advisory meetings with EMA are met. This will pave the way for a rapid and straightforward approval process. “When submitting to EMA, we will have a

Klaria changes the date of publication for its Q3 interim report to November 15

Today, Klaria Pharma Holding AB announces that company’s interim report for the third quarter of 2019 will be released on November 15. This change is due to the ongoing fusion process with Karessa Pharma Holding AB as announced on November 5, 2019.The original publication date for the interim report was November 28. Klaria’s updated financial calendar is available on the company’s website.

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Cartagena, Colombia

Free youth baseball clinics to feature Orlando Cabrera, Michael Barrett and other MLB AlumniColorado Springs, Colo. – Local Colombian youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series from Thursday, November 14th, 2019 to Sunday, November 17th, 2019. The free clinics feature former Major League Baseball players who will teach baseball skills, drills and life lessons for approximately 200 local youth. Players attending* include 2004 Boston Red Sox World Series

Sobi successfully completes acquisition of Dova Pharmaceuticals

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Dova Pharmaceuticals, Inc. (Dova) (NASDAQ: DOVA) announced today the completion of the acquisition of Dova by Sobi. Following the completion of Sobi’s successful tender offer to purchase outstanding shares of Dova for USD 27.50 per share, net to the seller thereof in cash, without interest and subject to any applicable withholding taxes, plus one non-transferable Contingent Value Right (CVR) which entitles Dova shareholders to an additional USD 1.50 per share upon approval of Doptelet® for use in Chemotherapy-Induced

Kungsleden's first new construction has begun – groundbreaking in Hyllie in Malmö today

Today, a ‘groundbreaking ceremony’ was held to mark the start of the construction of Eden, Kungsleden's new office building with a leasable area of approx. 8,000 square metres in Hyllie, Malmö. The total investment amounts to SEK 350 million and more than 50 per cent of the office space is already leased out, to Quick office among others. Attendees at the ceremony included (from left to right in the photo) Thomas Ellkvist, CEO at MVB Syd, Biljana Pehrsson, CEO of Kungsleden, Niklas Lénart, CEO of Quick Office and Britt-Marie Fagerström, Project Manager at the City of Malmö.

Invitation to cover the Awards Ceremony of the 30th Stockholm International Film Festival

On Friday, November 15 the prestigious Bronze Horse and Aluminium Horses are presented to the winners of the Stockholm International Film Festival. Stockholm Rising Star, Stockholm Impact Award, 1 Km Film and the Fipresci-award for "Best film" will also be presented during the evening. The Awards Ceremony is taking place at Göta Lejon. DATE: Friday, November 15 TIME: Doors open at 16:30, photographing and interviews on the red carpet between 17.00.-17.50. LOCATION: Göta Lejon  To cover the Awards Ceremony, please RSVP to pressekreterare@stockholmfilmfestival.se (press@

Orkla ASA: Lilleborg AS subject to investigation by the Norwegian Competition Authority

The Norwegian Competition Authority has today, 12 November 2019, on the basis of a ruling by Bergen city court dated 6 November 2019, commenced an inspection at Lilleborg AS (Orkla Home & Personal Care Norway), a wholly-owned subsidiary of Orkla ASA. According to the competition authorities, there is suspicion of breach of the competition act related to commercial terms between suppliers and the retail chains in the Norwegian market. Lilleborg assists the authorities in order to facilitate an efficient completion of the investigations. Orkla ASAOslo, 12 November 2019Ref.:Group

Net sales continued to grow in the third quarter, operating profit suppressed by Demolition business

DELETE GROUP OYJ, STOCK EXCHANGE RELEASE 12 November 2019 at 15:00 EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. DELETE GROUP OYJ Interim Review January–September 2019 (IFRS, unaudited)  NET SALES CONTINUED TO GROW IN THE THIRD QUARTER, OPERATING PROFIT SUPPRESSED BY DEMOLITION BUSINESS   HIGHLIGHTS OF JULY–SEPTEMBER 2019  · Net sales increased by 11% to EUR 57.7 (Q3 2018: 52.0) million  · EBITDA decreased by EUR -0.3

SpectraCure AB Quarterly Report (1 July to 30 September) 2019

Third quarter (1 July – 30 September 2019) · Other income amounted to TSEK 692 (215). · Profit after tax amounted to TSEK -3 054 (-1 922). · Corresponding to SEK -0,04 (-0,03) kr per share before and after diluted earnings. · Operating cash flow was TSEK -3 072 (-2 640). · Cash as of 30 September amounted to TSEK 25 421 (2 185) TSEK. · Equity ratio: 81 (85)%. 1 January – 30 September 2019 · Other income amounted to TSEK 2 005 (902). · Profit after tax amounted to TSEK -9 979 (-8 572). · Corresponding to SEK -0,12 (-0,13) kr per share before and after

There are no items matching the current filter
There are no more items matching the current filter
Back to top